Horizon Therapeutics PLC (HZNP) Stock Is Lower By -2.65% This Week: Buy, Hold, or Sell?
Wednesday, December 08, 2021 10:18 AM | InvestorsObserver Analysts
Mentioned in this article
Horizon Therapeutics PLC (HZNP) stock has gained 43.64% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives HZNP stock a score of 74 out of a possible 100.
That rank is influenced by a short-term technical score of 88. HZNP's rank also includes a fundamental score of 68. In addition to the average rating from Wall Street analysts, HZNP stock has a mean target price of $134.10. This means analysts expect the stock to add 30.63% over the next 12 months. The long-term technical score for HZNP is 66.
HZNP has an Overall Score of 74. Find out what this means to you and get the rest of the rankings on HZNP!
Horizon Therapeutics PLC (HZNP) stock is higher by 0.61% while the S&P 500 has gained 0.06% as of 10:14 AM on Wednesday, Dec 8. HZNP has gained $0.62 from the previous closing price of $102.04 on volume of 199,661 shares. Over the past year the S&P 500 is higher by 26.67% while HZNP has gained 43.64%. HZNP earned $2.31 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 44.36.
Click Here to get the full Stock Report for Horizon Therapeutics PLC stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
